We analyzed the clinical utility of molecular classification based on anatomical and histological background. The study was conducted on 457 patients treated for gastric cancer with additional information about microsatellite instability status. We divided the patients in three groups of molecular classification based on anatomical and histological background: proximal non-diffused, diffused, and distal non-diffused groups. These groups varied in terms of clinical and pathological factors as well as survival rates. The molecular classification based on anatomical and histological data seems to be a useful tool in a simple classification of gastric cancer
Gastric cancer, a highly heterogeneous disease, is the second leading cause of cancer death and the ...
Gastric cancer is the third most common cause of cancer related death. Although its incidence is glo...
Abstract The limited prognostic value of currently used histologic classifications of gastric cancer...
We analyzed the clinical utility of molecular classification based on anatomical and histological ba...
We analyzed the clinical utility of molecular classification based on anatomical and histological ba...
We analyzed the clinical utility of molecular classification based on anatomical and histological ba...
We analyzed the clinical utility of molecular classification based on anatomical and histological ba...
Gastric cancer (GC) is the third cause of cancer-related death worldwide, with a different distribut...
In Western countries the majority of gastric cancers (GC) are usually diagnosed in advanced stages r...
In Western countries the majority of gastric cancers (GC) are usually diagnosed in advanced stages r...
Despite some notable advances in the systemic management of gastric cancer (GC), the prognosis of pa...
Despite some notable advances in the systemic management of gastric cancer (GC), the prognosis of pa...
The relative contribution of tumour histology or molecular changes, compared with invasion pattern o...
AbstractGastric cancer, a highly heterogeneous disease, is the second leading cause of cancer death ...
Abstract The limited prognostic value of currently used histologic classifications of gastric cancer...
Gastric cancer, a highly heterogeneous disease, is the second leading cause of cancer death and the ...
Gastric cancer is the third most common cause of cancer related death. Although its incidence is glo...
Abstract The limited prognostic value of currently used histologic classifications of gastric cancer...
We analyzed the clinical utility of molecular classification based on anatomical and histological ba...
We analyzed the clinical utility of molecular classification based on anatomical and histological ba...
We analyzed the clinical utility of molecular classification based on anatomical and histological ba...
We analyzed the clinical utility of molecular classification based on anatomical and histological ba...
Gastric cancer (GC) is the third cause of cancer-related death worldwide, with a different distribut...
In Western countries the majority of gastric cancers (GC) are usually diagnosed in advanced stages r...
In Western countries the majority of gastric cancers (GC) are usually diagnosed in advanced stages r...
Despite some notable advances in the systemic management of gastric cancer (GC), the prognosis of pa...
Despite some notable advances in the systemic management of gastric cancer (GC), the prognosis of pa...
The relative contribution of tumour histology or molecular changes, compared with invasion pattern o...
AbstractGastric cancer, a highly heterogeneous disease, is the second leading cause of cancer death ...
Abstract The limited prognostic value of currently used histologic classifications of gastric cancer...
Gastric cancer, a highly heterogeneous disease, is the second leading cause of cancer death and the ...
Gastric cancer is the third most common cause of cancer related death. Although its incidence is glo...
Abstract The limited prognostic value of currently used histologic classifications of gastric cancer...